RxDoctor Payments Data

Richard Simman, MD

Plastic and Reconstructive Surgery · Toledo, OHNPI 1760448740

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (57.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Medline Industries LP accounts for 67.0% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $45,161 and has fallen 68.6% since, to $14,186 in 2025. Among plastic and reconstructive surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$76,152in general payments, 2019–2025

Across 162 payments — averaging $470.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medline Industries LP$51K
  • ETS Wound Care LLC$13K
  • Kerecis Limited$6K
  • Organogenesis Inc.$3K
  • Urgo Medical North America, LLC$2K
  • Smith+Nephew$558
  • plus $929 from 16 others
$3,627in research payments, 2019–2025

Across 3 payments — averaging $1208.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Kerecis Limited$4K

What the payments were for

  • Consulting fees$17,32523%
  • Speaking & faculty fees$43,84258%
  • Travel & lodging$8,13211%
  • Food & beverage$6,1758%
  • Education$6781%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$76,152 in reported general payments places this provider in the 95th percentile of 78 plastic and reconstructive surgery providers in Ohio.

See all plastic and reconstructive surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$59,670
Medicare patients
168
Services billed
848

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate94$963
Doxycycline Monohydrate12$290
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen25$207
Triamcinolone Acetonide19$192
Cephalexin25$164
Clindamycin Hcl13$107
Ciprofloxacin Hcl18$70

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →